116 related articles for article (PubMed ID: 7648800)
21. Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. II. Characterization of high- and low-affinity myo-inositol transport sites.
Cammarata PR; Chen HQ; Yang J; Yorio T
Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3572-80. PubMed ID: 1464503
[TBL] [Abstract][Full Text] [Related]
22. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model.
Akita M; Mizuno K; Matsubara A; Nakano K; Kurono M
Acta Med Okayama; 1993 Oct; 47(5):299-304. PubMed ID: 8273453
[TBL] [Abstract][Full Text] [Related]
23. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.
Dagher Z; Park YS; Asnaghi V; Hoehn T; Gerhardinger C; Lorenzi M
Diabetes; 2004 Sep; 53(9):2404-11. PubMed ID: 15331552
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes.
Chandra D; Jackson EB; Ramana KV; Kelley R; Srivastava SK; Bhatnagar A
Diabetes; 2002 Oct; 51(10):3095-101. PubMed ID: 12351453
[TBL] [Abstract][Full Text] [Related]
25. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
26. Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells.
Li W; Hamada Y; Nakashima E; Naruse K; Kamiya H; Akiyama N; Hirooka H; Takahashi N; Horiuchi S; Hotta N; Oiso Y; Nakamura J
Biochem Biophys Res Commun; 2004 Feb; 314(2):370-6. PubMed ID: 14733914
[TBL] [Abstract][Full Text] [Related]
27. Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Naruse K; Sasaki H; Mizuno K; Matsubara A; Kakuta H
Exp Physiol; 1995 Nov; 80(6):981-9. PubMed ID: 8962712
[TBL] [Abstract][Full Text] [Related]
28. The role of polyol pathway in high glucose-induced endothelial cell damages.
Oyama T; Miyasita Y; Watanabe H; Shirai K
Diabetes Res Clin Pract; 2006 Sep; 73(3):227-34. PubMed ID: 16624439
[TBL] [Abstract][Full Text] [Related]
29. Aldose reductase inhibitors.
Oka M; Kato N
J Enzyme Inhib; 2001 Dec; 16(6):465-73. PubMed ID: 12164386
[TBL] [Abstract][Full Text] [Related]
30. Cataract formation through the polyol pathway is associated with free radical production.
Kubo E; Miyoshi N; Fukuda M; Akagi Y
Exp Eye Res; 1999 Apr; 68(4):457-64. PubMed ID: 10192803
[TBL] [Abstract][Full Text] [Related]
31. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
Cheng HM; González RG
Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
[TBL] [Abstract][Full Text] [Related]
32. Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase.
Srivastava SK; Ansari NH; Hair GA; Awasthi S; Das B
Metabolism; 1986 Apr; 35(4 Suppl 1):114-8. PubMed ID: 3083202
[TBL] [Abstract][Full Text] [Related]
33. Effects of NaCl, glucose, and aldose reductase inhibitors on cloning efficiency of renal medullary cells.
Yancey PH; Burg MB; Bagnasco SM
Am J Physiol; 1990 Jan; 258(1 Pt 1):C156-63. PubMed ID: 2105652
[TBL] [Abstract][Full Text] [Related]
34. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
Gonzalez AM; Sochor M; Hothersall JS; McLean P
Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
[TBL] [Abstract][Full Text] [Related]
35. Effect of epalrestat, an aldose reductase inhibitor, on the generation of oxygen-derived free radicals in neutrophils from streptozotocin-induced diabetic rats.
Kashima K; Sato N; Sato K; Shimizu H; Mori M
Endocrinology; 1998 Aug; 139(8):3404-8. PubMed ID: 9681489
[TBL] [Abstract][Full Text] [Related]
36. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta.
Tesfamariam B; Palacino JJ; Weisbrod RM; Cohen RA
J Cardiovasc Pharmacol; 1993 Feb; 21(2):205-11. PubMed ID: 7679153
[TBL] [Abstract][Full Text] [Related]
37. Acetyl-L-carnitine corrects electroretinographic deficits in experimental diabetes.
Lowitt S; Malone JI; Salem A; Kozak WM; Orfalian Z
Diabetes; 1993 Aug; 42(8):1115-8. PubMed ID: 8325441
[TBL] [Abstract][Full Text] [Related]
38. High-performance liquid chromatographic analysis of glucose, fructose, sorbitol and low levels of the aldose reductase inhibitor sorbinil in human lens and plasma.
Lloyd P; Crabbe MJ
J Chromatogr; 1985 Oct; 343(2):402-6. PubMed ID: 3934205
[No Abstract] [Full Text] [Related]
39. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
Craven PA; DeRubertis FR
Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
[TBL] [Abstract][Full Text] [Related]
40. Time-dependent aspects of osmolyte changes in rat kidney, urine, blood and lens with sorbinil and galactose feeding.
Edmands SD; Hughs KS; Lee SY; Meyer SD; Saari E; Yancey PH
Kidney Int; 1995 Aug; 48(2):344-53. PubMed ID: 7564101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
